HP2 Laboratory, INSERM U1042, Grenoble Alpes University, Grenoble, France; EFCR Laboratory, Thorax and Vessels Division, Grenoble Alpes University Hospital, Grenoble, France.
IAME, INSERM UMR 1137, Paris Diderot University, Paris, France; Medical and Infectious Diseases Intensive Care Unit, Paris Diderot University and Bichat Hospital, Paris, France.
Lancet Respir Med. 2016 May;4(5):407-18. doi: 10.1016/S2213-2600(16)00054-0.
With the increase in the global prevalence of obesity, there is a parallel rise in the proportion of obese patients admitted to intensive care units, referred for major surgery or requiring long-term non-invasive ventilation (NIV) at home for chronic respiratory failure. We describe the physiological effect of obesity on the respiratory system mainly in terms of respiratory mechanics, respiratory drive, and patency of the upper airways. Particular attention is given to the prevention and the clinical management of respiratory failure in obese patients with a main focus on invasive and NIV in intensive care during the perioperative period and long-term use of NIV on return home. We also address other aspects of care of obese patients, including antibiotic dosing and catheter-related infections.
随着肥胖在全球的流行率不断增加,肥胖患者在重症监护病房(ICU)的住院比例、需要接受重大手术的比例或需要长期家庭无创通气(NIV)治疗慢性呼吸衰竭的比例也呈平行上升趋势。我们主要从呼吸力学、呼吸驱动和上呼吸道通畅性的角度来描述肥胖对呼吸系统的生理影响。特别关注肥胖患者呼吸衰竭的预防和临床管理,主要集中在围手术期 ICU 中的有创和 NIV 以及术后回家后的长期 NIV 使用。我们还涉及肥胖患者其他方面的护理,包括抗生素剂量和导管相关感染。